| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YMETH.2010.03.008 |
| P698 | PubMed publication ID | 20362673 |
| P2093 | author name string | Zdenko Herceg | |
| Anupam Paliwal | |||
| Thomas Vaissière | |||
| P2860 | cites work | MethyLight: a high-throughput assay to measure DNA methylation | Q24515378 |
| Human DNA methylomes at base resolution show widespread epigenomic differences | Q24633677 | ||
| Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing | Q24652350 | ||
| Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites | Q28187720 | ||
| The power and the promise of DNA methylation markers | Q28188233 | ||
| DNA methylation: a profile of methods and applications | Q28202469 | ||
| Conversion-specific detection of DNA methylation using real-time polymerase chain reaction (ConLight-MSP) to avoid false positives | Q28208403 | ||
| Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age | Q28505636 | ||
| COBRA: a sensitive and quantitative DNA methylation assay | Q34630070 | ||
| DNA alterations in body fluids as molecular tumor markers for urological malignancies | Q34696425 | ||
| Methods for detecting DNA methylation in tumors: from bench to bedside | Q36682427 | ||
| Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors | Q36729881 | ||
| DNA methylation as a therapeutic target in cancer | Q36760984 | ||
| Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors | Q37036306 | ||
| Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis | Q37453787 | ||
| Quantification of regional DNA methylation by liquid chromatography/tandem mass spectrometry | Q37610973 | ||
| Enzymatic regional methylation assay for determination of CpG methylation density | Q38334412 | ||
| Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing | Q41834670 | ||
| Quantitative methylation analysis using methylation-sensitive single-nucleotide primer extension (Ms-SNuPE). | Q44048654 | ||
| Methylation assay by nucleotide incorporation: a quantitative assay for regional CpG methylation density | Q44902638 | ||
| Quantitative analysis of DNA methylation after whole bisulfitome amplification of a minute amount of DNA from body fluids. | Q46003133 | ||
| Gene promoter methylation in plasma and sputum increases with lung cancer risk | Q47726867 | ||
| Quantification of DNA methylation in electrofluidics chips (Bio-COBRA). | Q51580788 | ||
| p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer. | Q53646727 | ||
| TP53andKRAS2Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study | Q57037815 | ||
| CpG island methylator phenotype in cancer | Q81080870 | ||
| P433 | issue | 3 | |
| P921 | main subject | DNA methylation | Q874745 |
| P304 | page(s) | 242-247 | |
| P577 | publication date | 2010-04-01 | |
| P1433 | published in | Methods | Q6823859 |
| P1476 | title | Quantitative detection of DNA methylation states in minute amounts of DNA from body fluids. | |
| P478 | volume | 52 |
| Q82891679 | A pyrosequencing assay for the quantitative methylation analysis of the PCDHB gene cluster, the major factor in neuroblastoma methylator phenotype |
| Q44600398 | A structural equation modelling approach to explore the role of B vitamins and immune markers in lung cancer risk |
| Q47140012 | An optimized rapid bisulfite conversion method with high recovery of cell-free DNA. |
| Q35543647 | Application of next-generation sequencing technology in forensic science |
| Q82294105 | A–Z of methylome analysis |
| Q36484114 | Cubic regression-based degree of correction predicts the performance of whole bisulfitome amplified DNA methylation analysis |
| Q38038406 | Detection of cancer-specific epigenomic changes in biofluids: powerful tools in biomarker discovery and application |
| Q58012142 | Detection strategies for methylated and hypermethylated DNA |
| Q27023830 | Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines |
| Q38544386 | Epigenetic mechanisms and therapeutic targets of chemotherapy resistance in epithelial ovarian cancer |
| Q28710498 | Epigenome-wide association studies for common human diseases |
| Q42549625 | High recovery of cell-free methylated DNA based on a rapid bisulfite-treatment protocol |
| Q35169860 | Identification of subgroup-specific miRNA patterns by epigenetic profiling of sporadic and Lynch syndrome-associated colorectal and endometrial carcinoma |
| Q28285049 | Lung cancer epigenetics: emerging biomarkers |
| Q84476181 | The determination of tissue-specific DNA methylation patterns in forensic biofluids using bisulfite modification and pyrosequencing |
| Q37257395 | The neural crest and cancer: a developmental spin on melanoma |
| Q37026617 | Utilizing Gold Nanoparticle Probes to Visually Detect DNA Methylation |
Search more.